SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-060033
Filing Date
2024-05-15
Accepted
2024-05-15 07:20:02
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rnlx-20240331.htm   iXBRL 10-Q 2257231
2 EX-31.1 rnlx-ex31_1.htm EX-31.1 11537
3 EX-31.2 rnlx-ex31_2.htm EX-31.2 12044
4 EX-32.1 rnlx-ex32_1.htm EX-32.1 7509
5 GRAPHIC img84505606_0.jpg GRAPHIC 17069
  Complete submission text file 0000950170-24-060033.txt   9087999

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rnlx-20240331.xsd EX-101.SCH 1666125
74 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20240331_htm.xml XML 1308968
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39387 | Film No.: 24947140
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)